Phyxiom
Pre-clinicalPhyxiom™ transforms the clinical outcomes for patients with uncontrolled asthma and COPD. Our technology is the result of over 12 years’ of clinical research and multiple randomised control trials developing a family of patented algorithms and software platforms for the management of chronic respiratory disease.Our mission is to replicate these better outcomes for the 540 million patients globally with either COPD or Asthma.
About
Phyxiom™ transforms the clinical outcomes for patients with uncontrolled asthma and COPD. Our technology is the result of over 12 years’ of clinical research and multiple randomised control trials developing a family of patented algorithms and software platforms for the management of chronic respiratory disease.Our mission is to replicate these better outcomes for the 540 million patients globally with either COPD or Asthma.
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile